Company Profile
Updated: 30-NOV-09Schering-Plough S.A.
Non-Quoted Public Company
Cantabria 2, Alcobendas, E-28109, Spain
()34 91 567 30 00, 34 91 567 31 17 fax, http://www.msd.com
Primary SIC: Medical Chemicals & Botanical Products, Primary NAICS: Medicinal and Botanical Manufacturing
Description: Manufacturing: Manufacture of pharmaceuticals, over-the-counter remedies and veterinary products
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
New Merck Begins Operations.(Company overview)
Pediatrics Week; 11/21/2009; 1821 words; ...completion of Merck's merger with Schering-Plough Corporation announced...considerable talents of Schering-Plough and Merck employees...patients." The company's corporate headquarters...Gwynedd, PA. The former Schering-Plough headquarters...
Ligand's JAK3 Research Collaboration Extended by Pfizer.
Blood Weekly; 11/19/2009; 1349 words; ...and psoriasis. Ligand's proprietary drug discovery...screening and one of the world's largest combinatorial chemical...Cephalon, GlaxoSmithKline, Schering-Plough, Pfizer and Wyeth Pharmaceuticals...uncertainties and reflect Ligand's judgment as of the date...
Fitch Downgrades Merck and Upgrades Schering-Plough to 'A+' Following Merger; Outlook Stable.
Biotech Week; 11/18/2009; 1441 words; ...Co., Inc. (Merck) and Schering-Plough Corp. (Schering-Plough) yesterday, Fitch Ratings has downgraded Merck's Issuer Default Rating (IDR...supported by the addition of Schering Plough's diversified and solidly protected...
Ligand Pharmaceuticals Announces Third Quarter Results.(Financial report)
Biotech Week; 11/18/2009; 2083 words; ...to the termination of our research collaboration with Schering-Plough Corporation. General and administrative expenses decreased...Metabasis Therapeutics, Inc. Consistent with Ligand's business strategy to acquire quality partnered and pipeline...
New Shire Board Member.
Vaccine Weekly; 11/18/2009; 448 words; ...Prior to that he was President of GSK's US Pharmaceuticals Business and before that SmithKline Beecham's North American Pharmaceuticals Business...Mr Stout worked for many years at Schering-Plough. Mr Stout holds directorships at Allos...
Recent News Articles
- Schering-Plough Reports Data From SAPHRIS asenapine Long-Term Schizophrenia Relapse Prevention Study.(Clinical report)
Biotech Week - September 30, 2009 - Zacks Bull and Bear of the Day Highlights: China Fire & Security, Hain Celestial, Merck, Schering-Plough and Sanofi-Aventis.
Business Wire - September 24, 2009 - News and FDA Updates for CNS Response (OTC:CNSO), Covance (NYSE:CVD), Schering-Plough (NYSE:SGP), Eli Lilly (NYSE:LLY).
M2 Presswire - September 21, 2009 - Schering-Plough Declares Quarterly Dividends on Common Shares and Mandatory Convertible Preferred Stock.
PR Newswire - September 18, 2009
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning